AAIC Abstract Submissions

Information on presentation types, themes and topics.

SUBMIT YOUR ABSTRACT

On This Page:

Presentation Types

Authors may select from three presentation formats when submitting an abstract for AAIC. These include:

AAIC Poster Presentation (individual)

AAIC Oral Presentation (individual)

AAIC Featured Research Session (FRS)

AAIC Travel Fellowships

A limited number of travel fellowships are available to AAIC presenting authors. Awarded in various packages, AAIC Travel Fellowships may include one, two or three of the following: complimentary AAIC registration, housing and/or airfare support.

Application process: In order to apply, the applicant must be indicated as the presenting author on a submitted abstract for AAIC and complete the travel fellowship application requirements in the last step of the abstract submission process. Learn more about AAIC Travel Fellowships.

Themes, Topics and Subtopics

Selection of a theme, topic and subtopic for the abstract allows submitters to "self-identify" the area in which the abstract best fits. This identification is the first step in sorting abstracts for the Scientific Program Committee, who will take this identification into consideration and group related abstracts with similar topics into the same session. Selection of a primary theme, topic and subtopic is required.

Theme: Basic Science and Pathogenesis

  • Topic: Genetics
    • Blood-borne markers of CNS disease
    • Endophenotypes
    • Epigenetics
    • Genetic factors of Alzheimer’s disease
    • Genetic factors of non-Alzheimer’s disease
    • Genetics of cognitive aging
    • Genetics of systems biology
  • Topic: Human Neuropathology
    • Alpha-synuclein
    • Amyloid
    • Clinico-pathologic correlations
    • Etiopathogenesis--links to brain disease
    • Imaging-pathologic correlations
    • Novel methods
    • Other
    • Proteinopathies
    • Selective vulnerability
    • Tau
    • Topography of pathology
    • Vascular
  • Topic: Molecular and Cell Biology
    • α-synuclein
    • APP/Abeta/Amyloid
    • Axonal transport
    • Calcium homeostasis
    • Cell cycle disruption
    • Endosomal-lysosomal dysfunction
    • Enzyme activities
    • Metabolic stress
    • Mitochondrial function/energetics
    • Neurodegeneration and neuroprotection
    • Neurofibrillary degeneration
    • Neuroinflammation
    • Neuronal cell death mechanisms (i.e. apoptosis)
    • Neurotrophin mechanisms
    • Other
    • Oxidative stress
    • Presenilins
    • Protein clearance/recycling
    • Protein-protein interactions
    • Protein synthesis
    • Proteostasis
    • Receptors
    • Seeding and spreading of proteinopathies
    • Signal transduction
    • Stem cells, IPS cells
    • Synaptic disruption
    • Tau
    • TDP-43
    • Vascular factors

Theme: Biomarkers

  • Topic: Biomarkers (non-neuroimaging)
    • Differential diagnosis
    • Longitudinal change over time
    • Method development and/or quality control
    • Multi-modal comparisons
    • Novel biomarkers
    • Plasma/serum/urine biomarkers
    • Prognostic utility
    • Use in clinical trial design and evaluation
  • Topic: Neuroimaging
    • Animal imaging
    • Differential diagnosis
    • Evaluating treatments
    • Imaging and genetics
    • Multi-modal comparisons
    • New imaging methods
    • Normal brain aging
    • Optimal neuroimaging measures for early detection
    • Optimal neuroimaging measures for tracking disease progression

Theme: Clinical Manifestations

  • Topic: Neuropsychiatry and Behavioral Neurology
    • Assessment/measurement of neuropsychiatric/behavioral and psychological symptoms
    • Behavioral neurology
    • Dementia
    • Mild cognitive impairment/early symptomatic disease
    • Neuropsychiatry
    • Non-pharmacologic interventions
    • Presymptomatic disease/prodromal disease/prodromal states
    • Treatment development and clinical trials
  • Topic: Neuropsychology
    • Computerized neuropsychological assessment
    • Early detection of cognitive decline with neuropsychological tests
    • Multicultural issues in assessment of dementia
    • Neuropsychological correlates of physiologic markers of cognitive decline/dementia
    • Neuropsychological profiles of dementia: Valid biomarkers?
    • Normal cognitive aging

Theme: Dementia Care and Psychosocial Factors

  • Topic: Dementia Care Research (research projects; nonpharmacological)
    • Assessment and care planning
    • Behavioral interventions
    • Community care
    • Cross-cultural studies and cultural/linguistic adaptations
    • Family/lay caregiving
    • Instrument development, program evaluation and translation
    • Long-term care
    • Therapeutic strategies and interventions
    • Use of technologies
  • Topic: Psychosocial Factors and Environmental Design
    • Environmental design and technology
    • Living with dementia and quality of life
    • Social networks

Theme: Dementia Care Practice

  • Topic: Dementia Care Practice (descriptive)
    • Implementation of person-centered care
    • Managing dementia-related behaviors
    • Other innovative programs and practices
    • Supportive and therapeutic environments
    • Transition and coordination of services
    • Workforce initiatives

Theme: Drug Development

  • Topic: Human
    • Human trials: Anti-amyloid
    • Human trials: Anti-tau
    • Human trials: Cognitive enhancement
    • Human trials: Inflammation
    • Human trials: Nutraceuticals and non-pharmacological interventions
    • Human trials: Other
    • Human trials: Other behavioral symptoms
    • Novel outcomes measures
    • Prevention (clinical)
    • Trial design
  • Topic: Nonhuman
    • Lead optimization studies
    • Natural products and nutraceuticals
    • Nonpharmacological interventions
    • Novel screening strategies
    • Target identification and validation studies: Amyloid
    • Target identification and validation studies: Cognitive enhancement and other behavioral symptoms
    • Target identification and validation studies: Inflammation and innate immunity
    • Target identification and validation studies: Neuronal and synaptic protection
    • Target identification and validation studies: Other
    • Target identification and validation studies: Proteostasis
    • Target identification and validation studies: Tau

Theme: Public Health

  • Topic: Epidemiology
    • Innovative methods in epidemiology (i.e. assessment methods, design, recruitment strategies, statistical methods, etc.)
    • Prevalence, incidence, and outcomes of MCI and dementia
    • Risk and protective factors in MCI and dementia
  • Topic: Health Services Research
    • Cost-effectiveness of treatment/prevention and diagnosis
    • Cost of care
    • Policy and plans
    • Services
  • Topic: Prevention (nonpharmacalogical)
    • Cognitive interventions
    • Exercise
    • Lifestyle factors (e.g., smoking, etc.)
    • Multidomain
    • Nutrition
    • Other


Become an ISTAART Member

Go beyond the conference — Network and collaborate year-round with a global community of leaders who are working to advance Alzheimer’s and dementia research.


JOIN ISTAART TODAY

Join the Conversation #AAIC21

Follow

Exhibitors

Exhibitors

Sponsors

Sponsorship

> 1200px
lg
> 992px
md
> 768px
sm
< 767px
xs